Search - tctmd.com

Displaying 301 - 320 of 2630

Sort: Relevancy | Date

News Daily News

Según un Gran Meta Análisis Parecida Mortalidad al cabo de 30 Días y 1 Año con TAVR Versus Cirugía

Michael O'Riordan

June 07, 2016

News Daily News

More Proof of Declining Paravalvular Regurgitation With Newest Balloon-Expandable TAVR Devices

Shelley Wood

June 07, 2016

News Daily News

Equivalent Mortality at 30 Days and 1 Year With TAVR vs Surgery, Says Large Meta-analysis

Michael O'Riordan

June 07, 2016

News Daily News

丹麦 TAVR 的演变可能对国家产生影响

L.A. McKeown

June 06, 2016

Presentation

Transcatheter Aortic Valve Implantation Versus Surgical Aortic Valve Replacement

Presenter: Giovanni Esposito

June 06, 2016

News Daily News

La Evolución de la TAVR en Dinamarca podría Tener Imlpicacines en Otros Países

L.A. McKeown

June 06, 2016

News Daily News

Evolution of TAVR in Denmark May Have Implications for Other Countries

L.A. McKeown

June 06, 2016

Presentation

Choice of Treatment for Aortic Valve Stenosis in the Era of TAVR in Eastern Denmark (2005-2015)

Presenter: Ole De Backer

June 01, 2016

News Conference News EuroPCR 2016

Studies Highlight Permanent Pacemaker Rates Among New-Generation TAVR Devices

Michael O'Riordan

May 23, 2016

News Conference News EuroPCR 2016

Valvular Interventions for the Asymptomatic and Low Risk: Coming Soon to a Cath Lab Near You?

Yael L. Maxwell

May 20, 2016

News Conference News EuroPCR 2016

Planned MitraClip Implantation Safe, Feasible After TAVR, Small Series Suggests

Yael L. Maxwell

May 20, 2016

News Conference News EuroPCR 2016

Embolic Protection in TAVR: If, When, What, and How Debated as Trials Wrap Up

Shelley Wood

May 20, 2016

Presentation EuroPCR 2016

Early Percutaneous Intervention for Valvular Disease …An Opportunity for Improving Patient’s Outcome

Presenter: Patrick Serruys

May 20, 2016

Presentation EuroPCR 2016

A Patient Level Pooled Analysis of NeuroProtection with the TriGuard Embolic DEFLECTion Device Compared to Unprotected Transcatheter Aortic Valve Replacement

Presenter: Alexandra Lansky

May 20, 2016

News Conference News EuroPCR 2016

No Safety Net: TAVR Can Be Done at Centers Without Surgical Backup, German Study Suggests

Michael O'Riordan

May 19, 2016

Presentation EuroPCR 2016

Impact of Coronary Artery Disease on Clinical Outcomes Among Patients Undergoing Transcatheter Aortic Valve Implantation: An Age- and Sex-Matched Cohort Study

Presenter: Anna Franzone

May 19, 2016

Presentation EuroPCR 2016

First Look at Long-term Durability of Transcatheter Heart Valves: Assessment of Valve Function up To 10-years After Implantation

Presenter: Danny Dvir

May 19, 2016

News Conference News EuroPCR 2016

Closer Look at Effects of CAD on TAVR Outcomes Unearths Grim Prognosis

Yael L. Maxwell

May 19, 2016

Presentation EuroPCR 2016

Transcatheter Mitral Valve Replacement in Native Mitral Valve Disease with Severe Mitral Annular Calcification

Presenter: Mayra Guerrero

May 18, 2016

News Conference News EuroPCR 2016

‘Obesity Paradox’ Alive, Well, and Mysterious After TAVR

Yael L. Maxwell

May 18, 2016

Advertisement

Según un Gran Meta Análisis Parecida Mortalidad al cabo de 30 Días y 1 Año con TAVR Versus Cirugía

More Proof of Declining Paravalvular Regurgitation With Newest Balloon-Expandable TAVR Devices

Equivalent Mortality at 30 Days and 1 Year With TAVR vs Surgery, Says Large Meta-analysis

丹麦 TAVR 的演变可能对国家产生影响

Transcatheter Aortic Valve Implantation Versus Surgical Aortic Valve Replacement

La Evolución de la TAVR en Dinamarca podría Tener Imlpicacines en Otros Países

Evolution of TAVR in Denmark May Have Implications for Other Countries

Choice of Treatment for Aortic Valve Stenosis in the Era of TAVR in Eastern Denmark (2005-2015)

Studies Highlight Permanent Pacemaker Rates Among New-Generation TAVR Devices

Valvular Interventions for the Asymptomatic and Low Risk: Coming Soon to a Cath Lab Near You?

Planned MitraClip Implantation Safe, Feasible After TAVR, Small Series Suggests

Embolic Protection in TAVR: If, When, What, and How Debated as Trials Wrap Up

Early Percutaneous Intervention for Valvular Disease …An Opportunity for Improving Patient’s Outcome

A Patient Level Pooled Analysis of NeuroProtection with the TriGuard Embolic DEFLECTion Device Compared to Unprotected Transcatheter Aortic Valve Replacement

No Safety Net: TAVR Can Be Done at Centers Without Surgical Backup, German Study Suggests

Impact of Coronary Artery Disease on Clinical Outcomes Among Patients Undergoing Transcatheter Aortic Valve Implantation: An Age- and Sex-Matched Cohort Study

First Look at Long-term Durability of Transcatheter Heart Valves: Assessment of Valve Function up To 10-years After Implantation

Closer Look at Effects of CAD on TAVR Outcomes Unearths Grim Prognosis

Transcatheter Mitral Valve Replacement in Native Mitral Valve Disease with Severe Mitral Annular Calcification

‘Obesity Paradox’ Alive, Well, and Mysterious After TAVR

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content